AU2549800A - Human adenosine a2b anti-receptor polyclonal antibodies - Google Patents
Human adenosine a2b anti-receptor polyclonal antibodiesInfo
- Publication number
- AU2549800A AU2549800A AU25498/00A AU2549800A AU2549800A AU 2549800 A AU2549800 A AU 2549800A AU 25498/00 A AU25498/00 A AU 25498/00A AU 2549800 A AU2549800 A AU 2549800A AU 2549800 A AU2549800 A AU 2549800A
- Authority
- AU
- Australia
- Prior art keywords
- polyclonal antibodies
- human adenosine
- receptor polyclonal
- receptor
- adenosine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Cell Biology (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES9900373 | 1999-02-15 | ||
| ES9900373A ES2147540B1 (en) | 1999-02-15 | 1999-02-15 | ADTIOSINE HUMAN ANTI RECEIVER ANTIBODIES ANTIBODIES A2B. |
| PCT/ES2000/000052 WO2000049051A1 (en) | 1999-02-15 | 2000-02-15 | Human adenosine a2b anti-receptor polyclonal antibodies |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2549800A true AU2549800A (en) | 2000-09-04 |
Family
ID=8307433
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU25498/00A Abandoned AU2549800A (en) | 1999-02-15 | 2000-02-15 | Human adenosine a2b anti-receptor polyclonal antibodies |
Country Status (3)
| Country | Link |
|---|---|
| AU (1) | AU2549800A (en) |
| ES (1) | ES2147540B1 (en) |
| WO (1) | WO2000049051A1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2020205753A1 (en) | 2019-01-11 | 2021-08-05 | Omeros Corporation | Methods and compositions for treating cancer |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5516894A (en) * | 1992-03-11 | 1996-05-14 | The General Hospital Corporation | A2b -adenosine receptors |
| GB2264948B (en) * | 1992-03-13 | 1996-10-16 | Merck & Co Inc | Human adenosine receptors |
-
1999
- 1999-02-15 ES ES9900373A patent/ES2147540B1/en not_active Expired - Fee Related
-
2000
- 2000-02-15 AU AU25498/00A patent/AU2549800A/en not_active Abandoned
- 2000-02-15 WO PCT/ES2000/000052 patent/WO2000049051A1/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| ES2147540B1 (en) | 2001-04-01 |
| WO2000049051A1 (en) | 2000-08-24 |
| ES2147540A1 (en) | 2000-09-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU1462300A (en) | Human pan-hcv human monoclonal antibodies | |
| AU1290001A (en) | Antibodies | |
| PT1818343E (en) | Antibodies against human il-12 | |
| AU4935000A (en) | Antibodies | |
| AU2001256325A1 (en) | Human and humanized fap-alpha-specific antibodies | |
| AU7676300A (en) | Human anti-adipocyte monoclonal antibodies and their use | |
| AU5441000A (en) | Human monoclonal antibody | |
| HUP0203371A3 (en) | Adenosine receptor antagonists and methods of making and using the same | |
| AU1598801A (en) | HGF-SF monoclonal antibody combinations | |
| AU2292301A (en) | Human kinases | |
| AU1073501A (en) | Histamine receptor | |
| AU1618500A (en) | Human cell surface receptor proteins | |
| AU2002222954A1 (en) | Seat complete measuring system | |
| AU4980999A (en) | A3 adenosine receptor antagonists | |
| AU5211299A (en) | Human checkpoint kinase | |
| AU2001277980A1 (en) | Human cytokine receptor | |
| EP1151006A4 (en) | Human g protein coupled receptor | |
| AU2452301A (en) | Protein methylarginine-specific antibodies | |
| AU6035398A (en) | Human c5a-like receptor | |
| AU1735801A (en) | Antibody against human kgfr | |
| AU2549800A (en) | Human adenosine a2b anti-receptor polyclonal antibodies | |
| GB9818915D0 (en) | Antibodies | |
| AU4849299A (en) | Human emr1-like g protein coupled receptor | |
| AU5046700A (en) | Diagnostic monoclonal antibody for LTiGTyersinia pestisLT/iGT | |
| AU7999300A (en) | Novel human phosphodiesterase zcytor13 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |